Summary:
A 26-week randomized, double-blinded, active controlled study comparing the safety of mometasone furoate/formoterol fumarate mdi fixed dose combination versus mometasone furoate mdi monotherapy in adolescents and adults with persistent asthma.
Qualified Participants Must:
• Have persistent asthma for at least 1-year
•
Use a daily asthma controller medication for at least 4 weeks
•
Have a history of at least one asthma exacerbation (attack) within a year
Qualified Participants May Receive:
Study medication, study related medical care and may be compensated for time and travel.